Search results
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
The Pilot News· 18 hours agoCelltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...
Stem cell treatments in Mexico linked to drug-resistant meningitis, joint infections
United Press International via Yahoo News· 22 hours agoAntibiotic-resistant meningitis or severe, long-lasting joint infections: That's what three U.S....
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 3 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Three drug-resistant infections in US tied to stem-cell injections in Mexico
Center for Infectious Disease Research and Policy· 22 hours agoThe first (patient B) was a man from Arizona who developed a right elbow osteoarticular infection...
Higher NSAID Dose Raises CVD Risk in Ankylosing Spondylitis
Medscape· 12 hours agoNSAIDs, the primary pain management therapy for AS, increased the risk for vascular events and...
Amgen (NASDAQ:AMGN) Rating Increased to Outperform at William Blair
ETF DAILY NEWS· 6 days agoAmgen (NASDAQ:AMGN – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Friday, MarketBeat ...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims - Comfort...
Benzinga· 7 days agoThe first-quarter 2024 earnings season is almost over as far as large drugmakers are concerned. Eli...